Notice of Investor Relations Event - Participation in Korea Investment & Securities NDR
-
NDR for domestic institutional investors on May 7, 2026 in Seoul
-
Sponsored by Korea Investment & Securities, 1:1 in-person meetings
-
Q1 2026 business update and Q&A session
-
IR materials to be posted on the company website prior to the event
KOSPI Filing Information
-
Filing: Corporate Briefing (IR) Holding (Notice Disclosure)
-
Company: Hanmi Pharm (128940)
-
Submission: Hanmi Pharm. Co., Ltd.
-
Receipt: 04-30-2026
-
Under KRX KOSPI Market Division